Together, our results demonstrate that genetic deficiency of TAOK3 in mice failed to mitigate the development of diet-induced NAFLD and had no impact on the progression of systemic glucose intolerance or insulin resistance in the context of obesity. Here, TAOK3 is linked to metabolic dysfunction-associated steatotic liver disease.